CFG
ABBV icon

Carr Financial Group’s AbbVie ABBV Stock Holding History

Carr Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
4,952
-81
-2% -$17.4K 0.29% 58
2026
Q1 		$1.09M Sell
5,033
-45
-0.9% -$9.98K 0.29% 60
2025
Q4 		$1.16M Sell
5,078
-77
-1% -$17.5K 0.31% 57
2025
Q3 		$1.19M Sell
5,155
-97
-2% -$19.8K 0.33% 58
2025
Q2 		$975K Buy
5,252
+40
+0.8% +$7.43K 0.29% 66
2025
Q1 		$1.09M Buy
5,212
+156
+3% +$30.3K 0.36% 53
2024
Q4 		$899K Sell
5,056
-218
-4% -$40.1K 0.28% 65
2024
Q3 		$1.04M Buy
5,274
+56
+1% +$10.5K 0.31% 61
2024
Q2 		$895K Buy
5,218
+145
+3% +$24K 0.28% 68
2024
Q1 		$924K Sell
5,073
-325
-6% -$56K 0.31% 63
2023
Q4 		$836K Sell
5,398
-93
-2% -$13.6K 0.31% 62
2023
Q3 		$776K Buy
5,491
+937
+21% +$138K 0.31% 63
2023
Q2 		$614K Buy
4,554
+469
+11% +$68.8K 0.24% 73
2023
Q1 		$651K Sell
4,085
-2,391
-37% -$366K 0.29% 71
2022
Q4 		$1.05M Buy
+6,476
New +$993K 0.55% 36

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Carr Financial Group's ABBV Position: Q2 2026 in Review

Carr Financial Group reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $17.4K and leaving 4,952 shares worth $1.25M. The position accounts for 0.29% of the portfolio, ranked #58.

Carr Financial Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Carr Financial Group held 4,952 shares of AbbVie worth $1.25M as of Q2 2026.
  • Carr Financial Group sold 81 AbbVie shares in Q2 2026, an estimated $17.4K.
  • AbbVie made up 0.29% of Carr Financial Group's portfolio in Q2 2026, its #58 holding.
  • Carr Financial Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Carr Financial Group's 13F filing for Q2 2026, filed 6 Aug 2026.